$0.79
0.38%
Nasdaq, Fri, Dec 27 2024
ISIN
US15117N5032
Symbol
CLSN

Celsion Corporation Stock price

$0.79
-0.06 7.36% 1M
-0.34 29.82% 6M
+0.11 16.62% YTD
+0.06 8.41% 1Y
-8.08 91.06% 3Y
-23.66 96.76% 5Y
-492.71 99.84% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
+0.00 0.38%
ISIN
US15117N5032
Symbol
CLSN
Sector

Key metrics

Market capitalization $11.50m
Enterprise Value $2.46m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
P/B ratio (TTM) P/B ratio 1.40
Revenue growth (TTM) Revenue growth -100.00%
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-20.95m
Free Cash Flow (TTM) Free Cash Flow $-18.22m
Cash position $10.31m
EPS (TTM) EPS $-1.89
P/E forward negative
Short interest 0.79%
Show more

Is Celsion Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Celsion Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Celsion Corporation forecast:

4x Buy
100%

Analyst Opinions

4 Analysts have issued a Celsion Corporation forecast:

Buy
100%

Financial data from Celsion Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
- -
-
100%
- Direct Costs 0.69 0.69
13% 13%
-
-0.69 -0.69
631% 631%
-
- Selling and Administrative Expenses 6.61 6.61
39% 39%
-
- Research and Development Expense 13 13
21% 21%
-
-20 -20
4% 4%
-
- Depreciation and Amortization 0.69 0.69
-
-
EBIT (Operating Income) EBIT -21 -21
5% 5%
-
Net Profit -19 -19
30% 30%
-

In millions USD.

Don't miss a Thing! We will send you all news about Celsion Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Celsion Corp . is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm engages in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.

Head office United States
CEO Stacy Lindborg
Employees 33
Founded 1982
Website imunon.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today